Description:
Rapidly advancing technology has created exciting opportunities for researchers and physicians who are trying to elucidate the causes of disease,
create predictive or diagnostic assays and develop effective therapeutic treatments. Large-scale and high-throughput genomic and proteomic studies are
generating vast amounts of data that are leading to the identification of drug targets and disease biomarkers. To overcome the challenge of sifting
through all of the gene and protein expression data to find clinically relevant information, scientists have created a new research tool called the
tissue microarray (TMA). TMAs allow hundreds of tissue specimens to be examined on a single microscope slide, greatly streamlining the processes of
drug discovery and clinical diagnosis.
Prepared as a complete market information source for companies wishing to capitalize on the increasing
popularity of this powerful, new technology, this report is based on a survey of over 250 researchers, physicians and technicians who use TMAs in
either research or clinical laboratories. To help companies that want to stay ahead of the competition by improving their service and product
offerings, it provides vital information on end-users' scientific objectives, instrumentation for production and analysis of TMAs, outsourcing
practices and preferred TMA suppliers.
The major objectives of this report are as follows:
- Determine research objectives of tissue microarrays users
- Ascertain uses and applications for tissue microarrays
- Identify sources of tissue microarrays and understand reasons for source selection
- Identify major suppliers of products and services related to tissue microarray production, processing and analysis
- Determine levels of satisfaction with existing products and services for tissue microarray research and identify unmet needs
- Estimate tissue microarray market growth based on current and projected throughput levels
View Cart
